#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lupus nephritis Infection in an immunocompromised host Malformation venous Conjunctivitis allergic Lymphangioma Ichthyosis Hodgkin's disease refractory Mucopolysaccharidosis I Desmoid tumour Nasopharyngeal cancer Wiskott-Aldrich syndrome Transitional cell cancer of the renal pelvis and ureter Systemic mastocytosis Follicle centre lymphoma follicular grade I, II – III Squamous cell carcinoma of the oral cavity More trials…

    Learn about Rare Diseases

    Fabry’s disease – Trials in Disease Vascular malformation – Treatment Glycogen storage disease type II Hepatoblastoma Ewing’s sarcoma metastatic – Trials in Disease Primary immunodeficiency syndrome Hereditary optic atrophy Toxic epidermal necrolysis – Diagnostics Langerhans’ cell histiocytosis – Basic Information Indolent systemic mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALKYLATING AGENTS Mk-0616 Rbl015.2 L-Threonine Sar441566 4-IODOPHENYLALANINE I-131 Berubicin Hydrochloride R2R01 Fluorouracil Sodium Clofarabine Abrocitinib Losmapimod Liquid Paraffin Onfekafusp Alfa Olive Oil, Refined Rilzabrutinib Rilvegostomig Thalidomide Roflumilast Riluzole More therapies…

    Learn about Your Condition

    Proteinuria Ewing's sarcoma metastatic Lung adenocarcinoma Fabry's disease Ependymoma malignant Benign prostatic hyperplasia Mental disorder Femur fracture Alcoholic liver disease Suicidal ideation Dyspnoea Inclusion body myositis Intestinal infarction Niemann-Pick disease Type IIa hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Bioequivalence Study of Amoxicillin/Clavulanic Acid Oral Suspension Compared with Reference Product in Healthy Adult Volunteers under Fed Conditions

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Heparin Sodium
    • Amoxicillin
    • Clavulanic Acid
    Czechia

  • A Study Comparing How the Body Absorbs Cefixime in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Cefixime
    • Cefixime Trihydrate
    Romania

  • Study of Rezafungin in Blood and Peritoneal Fluid for Patients with Suspected Intra-Abdominal Candidiasis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Rezafungin Acetate
    Spain

  • Study of 20-valent pneumococcal conjugate vaccine (PCV20) booster response in healthy adults aged 78-84 years

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 12F Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    The Netherlands

  • Study of acellular pertussis vaccine and its effect on whooping cough colonization in healthy adults using controlled human infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pertussis
    Investigated Drugs:
    • Azithromycin
    • TETANUS TOXOID
    The Netherlands

  • Study of rMenB+OMV NZ meningococcal group B vaccine immune response and safety in previously vaccinated healthy participants aged 10 to 20 years

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Meningococcal infection
    Investigated Drugs:
    • Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
    • Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide
    • Recombinant Neisseria Meningitidis Group B Nada Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide
    Finland Italy Spain
Previous Page
1 … 30 31 32 33 34 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!